Sign In
Buy NARI
$79.97
+0 (+0%)
At Close: May 16, 2025
Inari Medical to Present at the 43rd Annual Canaccord Growth Conference
04:01pm, Wednesday, 26'th Jul 2023
IRVINE, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Inari Medical to Announce Second Quarter 2023 Financial Results
04:01pm, Thursday, 13'th Jul 2023
IRVINE, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Reasons to Add Inari Medical (NARI) Stock to Your Portfolio
08:29am, Tuesday, 04'th Jul 2023
Inari Medical (NARI) continues to benefit from its commitment to understand the venous system. However, its dependency on adoption of products is a concern.
Inari Medical (NARI) Launches New Catheters to Address VTE
12:23pm, Thursday, 08'th Jun 2023
Inari Medical's (NARI) latest launches are expected to serve a wider patient pool by improving treatment options.
Here's Why You Should Retain Inari Medical (NARI) Stock Now
07:34am, Monday, 22'nd May 2023
Inari Medical (NARI) continues to benefit from its commitment to understand the venous system. However, its dependency on adoption of products is a concern.
Wall Street Analysts Think Inari Medical, Inc. (NARI) Could Surge 27.7%: Read This Before Placing a Bet
11:26am, Monday, 15'th May 2023
The consensus price target hints at a 27.7% upside potential for Inari Medical, Inc. (NARI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnin
Inari Medical: Targeting Underpenetrated $5.8 Billion Thromboembolism Market
01:00pm, Wednesday, 10'th May 2023
Inari Medical, Inc. has several devices for venous thrombectomy like The FlowTriever and ClotTriever devices. Several ongoing clinical trials and increasing quarterly sales have the potential to conti
Inari Medical (NARI) Q1 Earnings Top, Revenues Rise Y/Y
09:07am, Thursday, 04'th May 2023
Inari Medical's (NARI) first-quarter results benefit from significant progress made across all its growth drivers.
Inari Medical, Inc. (NARI) Reports Q1 Loss, Tops Revenue Estimates
07:02pm, Wednesday, 03'rd May 2023
Inari Medical, Inc. (NARI) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.06 per share a year ago.
Inari Medical to Present at the Bank of America 2023 Healthcare Conference
04:01pm, Tuesday, 02'nd May 2023
IRVINE, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Inari Medical to Announce First Quarter 2023 Financial Results
04:01pm, Thursday, 13'th Apr 2023
IRVINE, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Here's Why You Should Retain Inari Medical (NARI) Stock Now
12:12pm, Wednesday, 05'th Apr 2023
Inari Medical (NARI) continues to benefit from its commitment to understand the venous system. However, its dependency on the adoption of products is concerning.
Why Shares of Inari Medical Rose This Week
03:29pm, Thursday, 16'th Mar 2023
Inari Medical released positive news regarding its FlowTriever system to prevent pulmonary emboli. The company saw revenue rise by 38% in 2022.
Inari Medical: Reinvesting Heavily Into Growing International Markets
03:00pm, Friday, 03'rd Mar 2023
Inari Medical has solid top-line growth with expansion in core and new product lines. It continues to focus on reinvestment into future growth, especially in international markets.
Inari Medical (NARI) Q4 Earnings Beat, Revenues Rise Y/Y
06:46am, Wednesday, 01'st Mar 2023
Inari Medical's (NARI) fourth-quarter results benefit from significant progress made across all its growth drivers.
